QianZhaoMD

Journal Articles

• Peptide and non-peptide HIV fusion inhibitors.  
  Jiang S, Zhao Q, Debnath AK., Curr Pharm Des. 2002;8(8):563-80.
• XTT formazan widely used to detect cell viability inhibits HIV type 1 infection in vitro by targeting gp41.  
  Zhao Q, Ernst JT, Hamilton AD, Debnath AK, Jiang S., AIDS Res Hum Retroviruses. 2002 Sep 20;18(14):989-97.
• Development of a cell-based enzyme-linked immunosorbent assay for high-throughput screening of HIV type 1 entry inhibitors targeting the coreceptor CXCR4.  
  Zhao Q, Lu H, Schols D, De Clercq E, Jiang S., AIDS Res Hum Retroviruses. 2003 Nov;19(11):947-55.
• A novel assay to identify entry inhibitors that block binding of HIV-1 gp120 to CCR5.  
  Zhao Q, He Y, Alespeiti G, Debnath AK., Virology. 2004 Sep 1;326(2):299-309.
• Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.  
  Zhao Q, Ma L, Jiang S, Lu H, Liu S, He Y, Strick N, Neamati N, Debnath AK., Virology. 2005 Sep 1;339(2):213-25
• Join now to see all